Abstract
Mid-term Safety and Efficacy of Upadacitinib in Adolescents With Moderate-to-severe Atopic Dermatitis: A Real-life 34-Patient Multicenter Trial
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have